David Schubert - President and Chief Business Officer @ Acylin Therapeutics

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

David Schubert joined Accelerator Life Science Partners as Chief Operating Partner in 2014.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Rodeo Therapeutics	Accelerator Corp.	Yes	Series A - Rodeo Therapeutics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Chief Operating Partner

and

President and Chief Business Officer

. Additionally,

has had

past jobs including

President & CBO

Organization Name	Title At Company	Start Date	End Date
Accelerator Corp.	President & CBO	2005	2012
AmpliPhi Biosciences	Director, Communications and Strategic Relations; Senior Director, Strategic Initiatives	1997	—
Vector Securities International	Biotechnology Research Associate	—	—

Number of Current Board & Advisor Roles

is the

Board of Directors

Hub Name	CB Rank (Hub)
Manufacturing Early Stage Companies With Fewer Than 100 Employees	18,584
Therapeutics Companies with Early Stage Venture Funding	50,018
Seattle Companies With Fewer Than 1000 Employees (Top 10K)	12,099
Western US Pharmaceutical Companies	13,947
West Coast Therapeutics Companies	20,667
Greater Seattle Area Therapeutics Companies	67,748
Greater Seattle Area Biotechnology Companies	68,291
Western US Therapeutics Companies	16,724
United States Early Stage Companies With Fewer Than 10 Employees	32,269
Washington Early Stage Companies	79,086